This topic contains a solution. Click here to go to the answer

Author Question: A man who has secondary hypogonadism associated with pituitary dysfunction will begin exogenous ... (Read 7 times)

jCorn1234

  • Hero Member
  • *****
  • Posts: 545
A man who has secondary hypogonadism associated with pituitary dysfunction will begin exogenous testosterone therapy. The patient asks the primary care NP about future chances of fathering children. The NP should tell him that:
 
  a. fertility may improve with testosterone therapy.
  b. exogenous testosterone therapy will shut down sperm production.
  c. fertility can be restored when testosterone therapy is discontinued.
  d. he should store sperm ahead of the initiation of testosterone therapy.

Question 2

The parent of an 8-year-old child recently diagnosed with AD/HD verbalizes concerns about giving the child stimulants. The primary care NP should recommend:
 
  a. modafinil (Provigil).
  b. guanfacine (Intuniv).
  c. bupropion (Wellbutrin).
  d. atomoxetine (Strattera).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cclemon1

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

A
Men with secondary hypogonadism may become fertile with exogenous testosterone.

Answer to Question 2

D
Atomoxetine is not a stimulant medication but is thought to be as effective as stimulant medications. It is the only nonstimulant treatment approved by the U.S. Food and Drug Administration for AD/HD that has been shown to be safe, well tolerated, and efficacious in the treatment of children.




jCorn1234

  • Member
  • Posts: 545
Reply 2 on: Jul 24, 2018
Gracias!


nathang24

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Excellent

 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

For a complete list of videos, visit our video library